Stay updated with breaking news from Pharma Market. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alvotech's 2024 plans include several product launches around the world through various partners, but the forthcoming introduction of SIMLANDI® in the U.S. is in a market that is truly in the
India Business News: In Jan, the Indian pharma market saw 8% growth driven by respiratory therapies. Anti-asthma drugs like Foracort had double-digit growth, reflecting po
The revenues for the quarter grew nearly 10% while the net profit rose 16.5%. Both the domestic and US markets reported double-digit growth in revenues. The operating margin (Ebitda margin) rose 140 bps to 28.1%. The company has been charting a strong growth trajectory in recent quarters leading to the stock gaining almost 40% in the past one year.
/PRNewswire/ -- The "Clinical Trial Supply and Logistics Market for Pharma 2023-2033" report has been added to ResearchAndMarkets.com's offering. Global...
Visiongain has published a new report entitled Antisense Oligonucleotide (ASO) Therapeutics Market Report 2023-2033: Forecasts by Therapeutic Application...